NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 870 filers reported holding NOVARTIS A G in Q1 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $750,000 | -7.6% | 10,290 | 0.0% | 1.47% | -3.0% |
| Q3 2016 | $812,000 | -0.2% | 10,290 | +4.3% | 1.52% | -8.3% |
| Q2 2016 | $814,000 | +13.8% | 9,870 | 0.0% | 1.65% | +946.8% |
| Q1 2016 | $715,000 | -15.8% | 9,870 | 0.0% | 0.16% | -14.6% |
| Q4 2015 | $849,000 | -6.4% | 9,870 | 0.0% | 0.18% | -8.9% |
| Q3 2015 | $907,000 | -6.6% | 9,870 | 0.0% | 0.20% | +17.3% |
| Q2 2015 | $971,000 | -0.2% | 9,870 | 0.0% | 0.17% | +1.8% |
| Q1 2015 | $973,000 | +6.3% | 9,870 | 0.0% | 0.17% | -5.6% |
| Q4 2014 | $915,000 | -1.5% | 9,870 | 0.0% | 0.18% | -6.2% |
| Q3 2014 | $929,000 | +4.0% | 9,870 | 0.0% | 0.19% | +6.1% |
| Q2 2014 | $893,000 | +6.4% | 9,870 | 0.0% | 0.18% | -4.2% |
| Q1 2014 | $839,000 | +5.8% | 9,870 | 0.0% | 0.19% | +13.9% |
| Q4 2013 | $793,000 | +3.4% | 9,870 | -1.3% | 0.17% | -21.3% |
| Q3 2013 | $767,000 | +8.5% | 9,995 | 0.0% | 0.21% | -1.4% |
| Q2 2013 | $707,000 | – | 9,995 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |